P1339: IMPACT OF CLONAL HEMATOPOIESIS AND CANAKINUMAB ON NON-HEMATOLOGICAL MALIGNANCY: ANALYSIS OF THE CANTOS RANDOMIZED CLINICAL TRIAL

• Janghee Woo,
• Tingting Zhai,
• Fang Yang,
• Huilei Xu,
• Margaret Healey,
• Denise P. Yates,
• Michael T. Beste,
• David P. Steensma

Affiliations

Janghee Woo

1 Novartis Institutes for BioMedical Research, Cambridge, United States

Tingting Zhai

1 Novartis Institutes for BioMedical Research, Cambridge, United States

Fang Yang

1 Novartis Institutes for BioMedical Research, Cambridge, United States

Huilei Xu

1 Novartis Institutes for BioMedical Research, Cambridge, United States

Margaret Healey

1 Novartis Institutes for BioMedical Research, Cambridge, United States

Denise P. Yates

1 Novartis Institutes for BioMedical Research, Cambridge, United States

Michael T. Beste

1 Novartis Institutes for BioMedical Research, Cambridge, United States

David P. Steensma

1 Novartis Institutes for BioMedical Research, Cambridge, United States